Stent retriever thrombectomy for acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials, including THRACE

Abstract

Background and purposeEndovascular thrombectomy has become the reference therapy for patients with large vessel occlusion (LVO). However, no meta-analysis including the THRACE Trial has yet been reported. Thus, the present review assessed the outcomes of stent retriever thrombectomy added to medical care compared with medical care alone in LVO patients. Materials and methodsA systematic review was conducted of all randomized controlled trials (RCTs) examining stent retrievers added to medical care vs medical care alone in the MEDLINE, Embase and Web of Science databases. Meta-analyses of 90-day functional outcomes and mortality, and the occurrence of symptomatic intracranial hemorrhage (sICH), with thrombectomy plus medical care vs medical care alone were performed. ResultsSix multicenter RCTs involving 1673 patients were included. Successful recanalization (modified thrombolysis in cerebral ischemia grades 2b–3) was seen in 71% of patients (95% CI: 62–79%) after thrombectomy. These patients also had significantly higher rates of 90-day functional independence (mRS scores 0–2) compared with those receiving medical care only (OR: 2.14, 95% CI: 1.72–2.67; P<0.00001), as well as excellent outcomes (mRS scores 0–1, OR: 2.05, 95% CI: 1.58–2.67; P<0.00001). Also, the rate of functional independence was higher (OR: 2.39, 95% CI: 1.88–3.04; P<0.00001) in the subgroup analysis without the THRACE Trial. The effect of endovascular therapy on 90-day mortality was inconclusive (OR: 0.82, 95% CI: 0.62–1.07; P=0.15), and there was no increased occurrence of sICH (OR: 1.11, 95% CI: 0.66–1.88; P=0.70). ConclusionStent retriever thrombectomy added to medical care improved 90-day functional outcomes compared with medical care alone with no impact on mortality and risk of sICH in LVO patients.